Just a thought on some recent papers:
the facilitation of autophagy (ap) seems to be a - or even the - major pathway by which rapamycin exert its health and life extending action. The are roughly 2 kinds of ap:
a) non-selective ap targets all kinds of cellular components for recycling, to access building blocks for cellular metabolism in case of cellular starvation (in practice resulting from organismal starvation - think of caloric restriction)
This recycling can include damaged as well as undamaged components of the cell.
b) selective ap specifically targets damaged components of the cell.
This process is thought to be largely independent of starvation signaling, i.e. non reliant on mTOR signaling
https://www.ncbi.nlm...les/PMC4871809/
"Mechanisms of Selective Autophagy"
In 3 observational studies low dose glucosamine (about 1500 mg a day - I mean low dose, because the dose at which side effects occur is more than 10 times; in contrast to metformin and rapamycin) appeared to exert stupifyingly large tumor supressor effects of about 50% reduction in cancer death for long term consumers of frequent (i.e. daily) glucosamine. This is another plausible point for the narrative: in recent years there is emerging consensus, that many cancers are actually driven by mutant mitochondria. If glucosamine indeed preferably targets damaged mitochondria (as opposed to rapamycin) this could explain the results.
Glucosamine seems to manifest its benefits via different channels than mTOR. Should people start taking glucosamine in addition to their regular rapamycin/metformin supplements?
I know there is a lot of evidence for metformin(?), that's why most people in this forum are supplementing it and many take rapamycin. Nobody takes glucosamine for life extension like they do for metformin/rapa. I guess it's because the risk-reward ratio is not as good as metformin/rapamycin?